Thieno[2,3-d]pyrimidines as COX-2 inhibitors
Methods of inhibiting cyclooxygenase enzyme-2 (COX-2) using thieno[2,3-d]pyrimidine compounds. These methods can be effective for treating inflammation, pain, or any other COX-2 mediated disorder..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 19. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
VENUGOPALA KATHARIGATTA N [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-19, Last update posted on www.tib.eu: 2024-04-24, Last updated: 2024-04-26 |
|---|
| Patentnummer: |
US11932656 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003029468 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003029468 | ||
| 003 | DE-627 | ||
| 005 | 20240426160351.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240409s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003029468 | ||
| 035 | |a (EPA)US11932656 | ||
| 035 | |a (EPA)90245903 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a VENUGOPALA KATHARIGATTA N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Thieno[2,3-d]pyrimidines as COX-2 inhibitors |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-19, Last update posted on www.tib.eu: 2024-04-24, Last updated: 2024-04-26 | ||
| 520 | |a Methods of inhibiting cyclooxygenase enzyme-2 (COX-2) using thieno[2,3-d]pyrimidine compounds. These methods can be effective for treating inflammation, pain, or any other COX-2 mediated disorder. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a DEB PRAN KISHORE |e verfasserin |4 aut | |
| 700 | 0 | |a MAILAVARAM RAGHU PRASAD |e verfasserin |4 aut | |
| 700 | 0 | |a AL-SHAR'I NIZAR A |e verfasserin |4 aut | |
| 700 | 0 | |a GANGULY SWASTIKA |e verfasserin |4 aut | |
| 700 | 0 | |a GORAIN BAPI |e verfasserin |4 aut | |
| 700 | 0 | |a MUN LIM TSE |e verfasserin |4 aut | |
| 700 | 0 | |a HING JAMIE KOW KEAN |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 19. März |
| 773 | 1 | 8 | |g year:2024 |g day:19 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/90245903/publication/US11932656A1?q=US11932656 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 19 |c 03 | ||